1. Home
  2. ORIO vs ALLR Comparison

ORIO vs ALLR Comparison

Compare ORIO & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ORIO

Orion Digital Corp. Common Shares

N/A

Current Price

$0.66

Market Cap

23.0M

Sector

N/A

ML Signal

N/A

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.20

Market Cap

25.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORIO
ALLR
Founded
N/A
2004
Country
Canada
United States
Employees
188
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.0M
25.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ORIO
ALLR
Price
$0.66
$1.20
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.75
AVG Volume (30 Days)
27.8K
135.7K
Earning Date
03-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$320,000.00
Revenue This Year
$74.52
N/A
Revenue Next Year
$5.07
N/A
P/E Ratio
$4.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.77
52 Week High
$1.40
$2.35

Technical Indicators

Market Signals
Indicator
ORIO
ALLR
Relative Strength Index (RSI) 38.24 44.08
Support Level N/A $1.01
Resistance Level $0.96 $1.29
Average True Range (ATR) 0.07 0.09
MACD -0.01 0.01
Stochastic Oscillator 26.71 47.95

Price Performance

Historical Comparison
ORIO
ALLR

About ORIO Orion Digital Corp. Common Shares

Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

Share on Social Networks: